Xu, Peng-Peng <br/><br/>
JAM-A overexpression is related to disease progression in diffuse large B-cell lymphoma and downregulated by lenalidomide.  [electronic resource] 

 -  Scientific reports  08 2017 
 - 7433 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2045-2322 
<br/><br/><label>Standard No.: </label>10.1038/s41598-017-07964-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Cell Adhesion Molecules--genetics<br/>Cell Line, Tumor<br/>Disease Progression<br/>Epithelial-Mesenchymal Transition--drug effects<br/>Female<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Humans<br/>Lenalidomide--administration & dosage<br/>Lymphatic Metastasis<br/>Lymphoma, Large B-Cell, Diffuse--drug therapy<br/>Male<br/>Mice<br/>Neoplasm Invasiveness<br/>Nodal Protein--metabolism<br/>Prognosis<br/>Receptors, Cell Surface--genetics<br/>Signal Transduction--drug effects<br/>Transforming Growth Factor beta--metabolism<br/>Up-Regulation--drug effects<br/>Xenograft Model Antitumor Assays<br/>Zebrafish